FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891111805> ?p ?o ?g. }

• W2891111805 abstract "Though previous studies have investigated the efficacy characteristics of several different therapeutic modalities for locally advanced prostate cancer (LAPCa) patients, the available results remained unestablished. Therefore, the aim of this meta-analysis was conducted to clarify such differences.The online PubMed, EMBASE and Web of Science were comprehensively searched for relevant studies published before September 1st, 2017, and eventually eleven relevant studies met the inclusion criteria. The hazard odds ratios (HRs) with 95% credible interval (CI) were utilized to evaluate the efficacy characteristics of several different therapeutic modalities for LAPCa patients by Markov chain Monte Carlo methods.Five different therapeutic modalities were ultimately enrolled to shed light on the efficacy characteristics for LAPCa patients and seven different clinical outcomes were finally analyzed in this study. The cumulative rank probability of overall survival (OS) or cancer-specific survival (CSS) from best to worst was radiotherapy (RT) + orchiectomy, RT + long-term androgen deprivation therapy (LTADT), RT + short-term androgen deprivation therapy (STADT), LTADT and RT; RT + LTADT, RT + orchiectomy, RT + STADT, LTADT and RT, respectively. Meanwhile, in the terms of progression-free survival (PFS), biochemical failure rate (BFR), disease-free survival (DFS), local progression rate (LPR) and metastasis rate (MR), RT + LTADT as well as RT + STADT had a higher, whereas RT alone or LTADT had a relatively lower treatment effect.All in all, our results indicated that RT + LTADT or RT + orchiectomy was among the best two therapeutic regimens in the prognostic aspects of the patients with LAPCa. Furthermore, in consideration of reducing invasive treatment of eligible patients, RT + LTADT could yield better survival benefit of LAPCa patients, compared with others. In addition, the results of our analysis might provide a reference in the clinical selection. Larger sample sizes of strictly designed randomised controlled trials (RCTs) were wanted to validate our findings." @default.
• W2891111805 created "2018-09-27" @default.
• W2891111805 creator A5010420032 @default.
• W2891111805 creator A5010431622 @default.
• W2891111805 creator A5027833732 @default.
• W2891111805 creator A5029650765 @default.
• W2891111805 creator A5037086299 @default.
• W2891111805 creator A5057973270 @default.
• W2891111805 creator A5059507084 @default.
• W2891111805 creator A5061445062 @default.
• W2891111805 creator A5068176076 @default.
• W2891111805 creator A5076666539 @default.
• W2891111805 creator A5077063251 @default.
• W2891111805 creator A5087798680 @default.
• W2891111805 date "2018-09-01" @default.
• W2891111805 modified "2023-10-16" @default.
• W2891111805 title "Efficacy characteristics of different therapeutic modalities for locally advanced prostate cancer: a Bayesian network meta-analysis of randomized controlled trials" @default.
• W2891111805 cites W1872476938 @default.
• W2891111805 cites W1969704350 @default.
• W2891111805 cites W1978460595 @default.
• W2891111805 cites W1981663805 @default.
• W2891111805 cites W1984192990 @default.
• W2891111805 cites W1985587689 @default.
• W2891111805 cites W1986114421 @default.
• W2891111805 cites W1994334230 @default.
• W2891111805 cites W2016739154 @default.
• W2891111805 cites W2025317506 @default.
• W2891111805 cites W2026385036 @default.
• W2891111805 cites W2028870903 @default.
• W2891111805 cites W2040970243 @default.
• W2891111805 cites W2045276800 @default.
• W2891111805 cites W2061131544 @default.
• W2891111805 cites W2071879495 @default.
• W2891111805 cites W2074421032 @default.
• W2891111805 cites W2086154155 @default.
• W2891111805 cites W2088095316 @default.
• W2891111805 cites W2094315815 @default.
• W2891111805 cites W2095761465 @default.
• W2891111805 cites W2102345320 @default.
• W2891111805 cites W2105669432 @default.
• W2891111805 cites W2106285196 @default.
• W2891111805 cites W2107328434 @default.
• W2891111805 cites W2108864389 @default.
• W2891111805 cites W2110881680 @default.
• W2891111805 cites W2111603192 @default.
• W2891111805 cites W2113144077 @default.
• W2891111805 cites W2116641263 @default.
• W2891111805 cites W2117511763 @default.
• W2891111805 cites W2123230901 @default.
• W2891111805 cites W2128365260 @default.
• W2891111805 cites W2133531206 @default.
• W2891111805 cites W2142359566 @default.
• W2891111805 cites W2144498681 @default.
• W2891111805 cites W2144625636 @default.
• W2891111805 cites W2146599397 @default.
• W2891111805 cites W2147988554 @default.
• W2891111805 cites W2148386014 @default.
• W2891111805 cites W2148539277 @default.
• W2891111805 cites W2159700397 @default.
• W2891111805 cites W2159804269 @default.
• W2891111805 cites W2163120057 @default.
• W2891111805 cites W2291059315 @default.
• W2891111805 cites W2346061096 @default.
• W2891111805 cites W2410650233 @default.
• W2891111805 cites W2475261460 @default.
• W2891111805 cites W2570618306 @default.
• W2891111805 cites W2727380696 @default.
• W2891111805 cites W2727405061 @default.
• W2891111805 cites W2761955954 @default.
• W2891111805 doi "https://doi.org/10.21037/atm.2018.08.38" @default.
• W2891111805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6186551" @default.
• W2891111805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30370285" @default.
• W2891111805 hasPublicationYear "2018" @default.
• W2891111805 type Work @default.
• W2891111805 sameAs 2891111805 @default.
• W2891111805 citedByCount "2" @default.
• W2891111805 countsByYear W28911118052020 @default.
• W2891111805 countsByYear W28911118052021 @default.
• W2891111805 crossrefType "journal-article" @default.
• W2891111805 hasAuthorship W2891111805A5010420032 @default.
• W2891111805 hasAuthorship W2891111805A5010431622 @default.
• W2891111805 hasAuthorship W2891111805A5027833732 @default.
• W2891111805 hasAuthorship W2891111805A5029650765 @default.
• W2891111805 hasAuthorship W2891111805A5037086299 @default.
• W2891111805 hasAuthorship W2891111805A5057973270 @default.
• W2891111805 hasAuthorship W2891111805A5059507084 @default.
• W2891111805 hasAuthorship W2891111805A5061445062 @default.
• W2891111805 hasAuthorship W2891111805A5068176076 @default.
• W2891111805 hasAuthorship W2891111805A5076666539 @default.
• W2891111805 hasAuthorship W2891111805A5077063251 @default.
• W2891111805 hasAuthorship W2891111805A5087798680 @default.
• W2891111805 hasBestOaLocation W28911118051 @default.
• W2891111805 hasConcept C102652120 @default.
• W2891111805 hasConcept C121608353 @default.
• W2891111805 hasConcept C126322002 @default.
• W2891111805 hasConcept C143998085 @default.
• W2891111805 hasConcept C168563851 @default.
• W2891111805 hasConcept C207103383 @default.
• W2891111805 hasConcept C2777899217 @default.
• W2891111805 hasConcept C2780192828 @default.

• next